Skip to main content

Caleium Pharm:Ph3 CAEL-101-301 AL Amyloidosis

Clinical Trial Grant
Duke Scholars

Awarded By

Caelum BioSciences, Inc

Start Date

June 16, 2021

End Date

March 28, 2025
 

Awarded By

Caelum BioSciences, Inc

Start Date

June 16, 2021

End Date

March 28, 2025